Ulthera and Ulthera Prime are different device generations
Prime is the successor device, but Korean clinics do not label the two consistently and both are often written simply as Ulthera. Across seven Gangnam clinics, the share of Ulthera pages naming Prime ranged from 0% to 60%.
Last checked:
Ulthera Prime is the successor to Ulthera, and the two generations are frequently presented under the single label “Ulthera”.
Ulthera is a microfocused ultrasound (MFU) lifting device, and Ulthera Prime is its successor. The principle is identical — focused ultrasound delivers heat into the deep dermis to induce tissue contraction and a healing response — with the newer generation presented as improved in how the treatment area is visualised and in speed.
The difficulty is labelling. Clinics distinguish generations inconsistently.
| Labelling pattern | What it tells you |
|---|---|
| Both devices held and labelled separately | The generation is determined |
| Prime only | Determined as Prime |
| Written as “Ulthera” with no generation | Not determined |
How far the labelling varies
Counted by retrieving the sitemaps of seven Gangnam-area clinic websites on 13 August 2026, measuring what share of Korean-language pages covering Ulthera explicitly named Prime.
| Clinic | Ulthera pages | Naming Prime | Share |
|---|---|---|---|
| GU Clinic | 15 | 9 | 60.0% |
| Seye Clinic | 27 | 14 | 51.9% |
| V&MJ Dermatology | 23 | 1 | 4.3% |
| Here Dermatology | 1 | 0 | 0.0% |
| Nine Dermatology Gangnam | 0 | — | — |
| Toxnfill Gangnam | 0 | — | — |
| PHD Dermatology Apgujeong | 0 | — | — |
More material does not mean clearer generation labelling. V&MJ Dermatology named Prime on 1 of 23 Ulthera pages, while GU Clinic, with fewer pages, had the highest share. Three of the seven had no Korean-language Ulthera page at all.
What the literature settles, and what it does not
| Item | Status |
|---|---|
| Skin tightening effect of microfocused ultrasound | Reported in systematic review |
| Difference in outcome by operator or device generation | No standardised comparative evidence |
| Objective outcome measures | Flagged as needing improvement in the 2023 review |
The 2023 systematic review screened 693 studies and included 16, reporting brow lifts of 0.47–1.7 mm and submental area reductions of 26–45 mm². At day 90, 92% showed improvement in tightening or wrinkles — but patient-reported improvement was lower, at 42% by day 90 and 53% by day 360. That gap between assessor and self-rating is worth carrying into a consultation about expectations. Moderate pain and transient erythema were common; rare complications including dysaesthesia, bruising and mandibular burns were reported in 2%.
What to verify
- Device name — Ulthera or Prime. Confirm at consultation rather than from the website.
- Genuine-product disclosure — varies by clinic. Two of the seven above disclosed authenticity certification, and for one of those it concerned Thermage rather than Ulthera.
- Operator — outcomes differ by operator with the same device, and that difference appears on no website.
From the source
Ulthera Prime is the successor to Ulthera. The principle is the same — ultrasound delivers heat to deep skin layers to induce contraction — and it is presented as an improved generation in how the treatment area is checked and in treatment speed.
The problem is that clinic labelling is not standardised. (…) All three patterns are mixed together, so “we do Ulthera” does not tell you which device it is.
— Ultherapy in Gangnam: 7 Dermatology Clinics Compared — Device Generation Labeling, Published Content, Clinic Hours (kbeautyguide, 13 Aug 2026).
Related literature
- Contini M, Hollander MHJ, Vissink A, Schepers RH, Jansma J, Schortinghuis J. A Systematic Review of the Efficacy of Microfocused Ultrasound for Facial Skin Tightening. Int J Environ Res Public Health 2023;20(2):1522. PMID 36674277 · doi:10.3390/ijerph20021522 → Sixteen studies selected from 693. Reported brow lifts of 0.47–1.7 mm, submental reductions of 26–45 mm² and 92% improvement at day 90, against patient self-rating of 42% (day 90) to 53% (day 360), and concluded that better objective outcome measures are needed.
- Vachiramon V, et al. Microfocused Ultrasound in Regenerative Aesthetics — A Narrative Review on Mechanisms of Action and Clinical Outcomes. J Cosmet Dermatol 2025;24(2):e16658. PMID 39501429 → A narrative review of mechanisms of action and clinical outcomes for microfocused ultrasound.
Sources: clinic website sitemaps as retrieved on 13 August 2026 (per the source article). Generation labelling reflects clinic wording, not manufacturer documentation. Last checked 2026-08-24.
Frequently asked questions
How does Ulthera Prime differ from Ulthera?
Prime is the successor device. The principle is the same — focused ultrasound delivers heat to deep skin layers to induce contraction — and it is presented as an improved generation in how the treatment area is visualised and in treatment speed.
If a clinic page just says Ulthera, which device is it?
It is not determined. Some clinics hold both devices and label them separately, some offer only Prime, and some do not distinguish generations at all. The wording alone does not settle it, so ask for the device name at consultation.
Is the effect of microfocused ultrasound supported in the literature?
A 2023 systematic review of 16 studies reported brow lifts of 0.47 to 1.7 mm and improvement in skin tightening or wrinkles in 92% of patients at day 90. Patient-reported improvement was lower, at 42% by day 90.